Interferon-λ in HCV Infection and Therapy Dahkki Michael D. Robek, Nicole E. Pagliaccetti

Viečča ollesdeavstta

Epigenetic reprogramming of the type III interferon response potentiates antiviral activity and suppresses tumor growth. Dahkki Siyuan Ding, William Khoury-Hanold, Akiko Iwasaki, Michael D Robek

Viečča ollesdeavstta

Virus-based vaccine vectors with distinct replication mechanisms differentially infect and activate dendritic cells Dahkki Carolina Chiale, Anthony M. Marchese, Yoichi Furuya, Michael D. Robek

Viečča ollesdeavstta

Functional characterization of the putative hepatitis B virus core protein late domain using retrovirus chimeras. Dahkki Mayra L Garcia, Tracy D Reynolds, Walther Mothes, Michael D Robek

Viečča ollesdeavstta

CD4+ T cells reverse surface antigen persistence in a mouse model of HBV replication Dahkki Jacob T. Bailey, Safiehkhatoon Moshkani, Catherine Rexhouse, Jesse L. Cimino, Michael D. Robek

Viečča ollesdeavstta

Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis B Dahkki Carolina Chiale, Timur O. Yarovinsky, Stephen W. Mason, Bhaskara R. Madina, Manisha Menon, Marie M. Krady, Safiehkhatoon Moshkani, Anasuya Chattopadhyay Pal, Bijan Almassian, John K. Rose, Michael D. Robek, Valerian Nakaar

Viečča ollesdeavstta

Virus-like Vesicles Expressing Multiple Antigens for Immunotherapy of Chronic Hepatitis B Dahkki Timur O. Yarovinsky, Stephen W. Mason, Manisha Menon, Marie M. Krady, Maria Haslip, Bhaskara R. Madina, Xianyong Ma, Safiehkhatoon Moshkani, Carolina Chiale, Anasuya Chattopadhyay Pal, Bijan Almassian, John K. Rose, Michael D. Robek, Valerian Nakaar

Viečča ollesdeavstta